InsiderClue
← All stocks

PMV Pharmaceuticals, Inc.

PMVP Net buying
CIK 0001699382 #4532 in the set updated 22 Sep 2026
Bought (120 mo)
$70.38M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$61.94M
$0.00 on a plan · $3.14M straight out of an exercise
Sold at will
$58.80M
149 of 181 sales
Net
+$8.44M
+$11.58M against sales at will

By person

18 insiders · 203 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Schroeder Thilo
Director
—
$38.34M (97)
−$38.34M
2,687,236
5.03%
$4.08M
+106.5%
Boxer Capital, LLC entity
Former 10% Owner
$17.10M (1)
—
+$17.10M
2,329,073
4.36%
$3.54M
—
RA CAPITAL MANAGEMENT, L.P. entity
10% owner
$17.10M (1)
—
+$17.10M
1,710,265
3.20%
$2.60M
—
Thompson Peter A.
Director
$17.10M (2)
—
+$17.10M
114,039
0.2133%
$173.34K
—
Euclidean Capital LLC entity
10% owner
—
$6.36M (30)
−$6.36M
259,700
0.4858%
$394.74K
—
ORBIMED ADVISORS LLC entity
10% owner
$17.10M (2)
$13.30M (7)
+$3.80M
5,089,330
9.52%
$7.74M
+4,382%
Mack David Henry
President and CEO
—
$1.56M (6) scheduled
−$1.56M
673,394
1.26%
$1.02M
—
INTERWEST PARTNERS X LP entity
10% owner
$990.00K (1)
—
+$990.00K
4,502,480
8.42%
$6.84M
+811,158%
ORONSKY ARNOLD L
Director
$990.00K (1)
—
+$990.00K
6,469,356
12.10%
$9.83M
—
Alland Leila
Chief Medical Officer
—
$853.20K (14) scheduled
−$853.20K
45,909
0.0859%
$69.78K
+9,647%
Kung Winston
COO, CFO
—
$607.80K (4) scheduled
−$607.80K
10,600
0.0198%
$16.11K
+100.6%
LEVINE ARNOLD J
Director
—
$568.31K (7)
−$568.31K
409,842
0.7667%
$622.96K
−4.1%
Jalota Deepika
Chief Development Officer
—
$171.03K (4) scheduled
−$171.03K
89,959
0.1683%
$136.74K
+1,797%
Heyman Richard A.
Director
—
$126.94K (9) scheduled
−$126.94K
0
0.0000%
$0.00
—
Carulli Michael
Chief Financial Officer
—
$34.42K (2)
−$34.42K
60,146
0.1125%
$91.42K
+563.4%
Ticktin Robert
General Counsel & COO
—
$24.65K (1)
−$24.65K
98,695
0.1846%
$150.02K
−19.0%
Nextech V Oncology S.C.S., SICAV-SIF
Former 10% Owner
—
—
—
2,528,290
4.73%
$3.84M
—
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
Former 10% Owner
—
—
—
760,267
1.42%
$1.16M
—

Individual transactions

32
Insider
Date
Role
Action
Shares
Price
Amount
Alland Leila
9 Sep 2021
Chief Medical Officer
Sold after exercise
100
$30.25
$3.03K
Alland Leila
7 Sep 2021
Chief Medical Officer
Sold after exercise
3,900
$30.25
$117.98K
Jalota Deepika
17 Aug 2021
SVP, Regulatory Affairs and QA
Sold after exercise
2,896
$33.78
$97.81K
Alland Leila
9 Aug 2021
Chief Medical Officer
Sold after exercise
224
$36.69
$8.22K
Alland Leila
9 Aug 2021
Chief Medical Officer
Sold after exercise
2,049
$32.66
$66.91K
Alland Leila
9 Aug 2021
Chief Medical Officer
Sold after exercise
2,198
$35.06
$77.07K
Kung Winston
3 Aug 2021
COO, CFO
Sold after exercise
4,500
$33.82
$152.18K
Mack David Henry
21 Jul 2021
President and CEO
Sold after exercise
26,767
$35.76
$957.09K
Mack David Henry
20 Jul 2021
President and CEO
Sold after exercise
1,029
$35.53
$36.56K
Kung Winston
8 Jul 2021
COO, CFO
Sold after exercise
4,500
$33.75
$151.88K
Alland Leila
7 Jul 2021
Chief Medical Officer
Sold after exercise
2,049
$32.66
$66.91K
Alland Leila
7 Jul 2021
Chief Medical Officer
Sold after exercise
1,951
$31.93
$62.30K
Mack David Henry
28 Jun 2021
President and CEO
Sold after exercise
204
$35.53
$7.25K
Alland Leila
7 Jun 2021
Chief Medical Officer
Sold after exercise
1,367
$34.00
$46.48K
Alland Leila
7 Jun 2021
Chief Medical Officer
Sold after exercise
2,633
$33.39
$87.90K
Kung Winston
4 Jun 2021
COO, CFO
Sold after exercise
4,500
$33.75
$151.88K
Heyman Richard A.
1 Jun 2021
Director
Sold after exercise indirect
2
$34.67
$69.34
Heyman Richard A.
1 Jun 2021
Director
Sold after exercise indirect
209
$33.79
$7.06K
Heyman Richard A.
1 Jun 2021
Director
Sold after exercise indirect
764
$32.15
$24.56K
Heyman Richard A.
1 Jun 2021
Director
Sold after exercise indirect
2
$34.67
$69.34
Heyman Richard A.
1 Jun 2021
Director
Sold after exercise indirect
230
$33.75
$7.76K
Heyman Richard A.
1 Jun 2021
Director
Sold after exercise indirect
743
$32.16
$23.90K
Heyman Richard A.
1 Jun 2021
Director
Sold after exercise indirect
5
$34.67
$173.35
Heyman Richard A.
1 Jun 2021
Director
Sold after exercise indirect
553
$33.61
$18.59K
Heyman Richard A.
1 Jun 2021
Director
Sold after exercise indirect
1,392
$32.15
$44.75K
Mack David Henry
21 May 2021
President and CEO
Sold after exercise
6,207
$35.71
$221.64K
Mack David Henry
20 May 2021
President and CEO
Sold after exercise
7,793
$35.60
$277.45K
Alland Leila
7 May 2021
Chief Medical Officer
Sold after exercise
158
$35.49
$5.61K
Alland Leila
7 May 2021
Chief Medical Officer
Sold after exercise
3,842
$34.80
$133.70K
Kung Winston
3 May 2021
COO, CFO
Sold after exercise
4,500
$33.75
$151.88K
Alland Leila
7 Apr 2021
Chief Medical Officer
Sold after exercise
28
$34.42
$963.79
Alland Leila
7 Apr 2021
Chief Medical Officer
Sold after exercise
3,972
$33.86
$134.48K
Show all 203 transactions →

What was left out

Form 4 filings counted 159
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 17
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 32
Sales at will 149
Transactions with no price 0
Shares from compensation/vesting 41,009,995
Sales filed before the plan box existed 138
History held since 29 Sep 2020